Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
880
Trial Sponsor
Clinical Trial Start Date
2007
0Study Completion Date
2007
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Interventional Trial Phase
Phase 20
Participating Facility
Official Name
A Study to Investigate the Safety and Efficacy of Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus0
Last Updated
November 30, 2007
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Study summary
The purpose of this study is to determine the safety, tolerability and efficacy of intranasal ALN-RSV01 versus placebo, administered once daily for 5 days to a healthy male volunteers experimentally inoculated with RSV
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
